Labcyte Inc. Announces Patent on Applications of Multi-Layer Droplets

Labcyte Inc. announced that its seventh U.S. patent 6,642,061 entitled “Use of Immiscible Fluids in Droplet Ejection Through Application of Focused Acoustic Energy” issued today. This technology has applications in the use of multiple layer droplets for miniaturized arrayed assays.

November 04, 2003
Sunnyvale, CA
Sunnyvale, CA, November 4, 2003–Labcyte Inc. announced that its seventh U.S. patent 6,642,061 entitled “Use of Immiscible Fluids in Droplet Ejection Through Application of Focused Acoustic Energy” issued today. This technology has applications in the use of multiple layer droplets for miniaturized arrayed assays.  

Labcyte Inc. is a privately held company headquartered in Sunnyvale, California. The company provides a broad range of systems for liquid handling and microwell plate processing as well as an extensive line of plastic consumables for use on its own instruments and those from other manufacturers. The 100 nanoliter to 300 microliter liquid transfer range is covered by a collection of instruments known for their small footprint and ease of conversion among formats. For transfers below 100 nanoliters, Labcyte is developing the acoustic droplet ejection (ADE) with broad applications in the life science including dispensing equipment, assay systems, particle manufacturing, microarrays, and living cell transfer devices. The company’s initial ADE-based product, the Echo 550, is a system for precisely transferring low nanoliter volumes of potential drug compounds into assay plates. Picoliter has 7 issued U. S. patents and 30 applications pending with the USPTO as well as additional international filings.

To lean more about Labcyte Inc., please visit our new website, www.labcyte.com.